We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

Closeup of a chemotherapy IV in a patient's hand.
News

Study Uncovers How Virus Causes Cancer

In high-risk groups, Kaposi's sarcoma-associated herpesvirus (KSHV) can trigger aggressive cancers. Research has shown how KSHV drives cell metabolism and proliferation. Inhibiting this process can block lymphoma progression and shrink existing tumors in preclinical models.
Cancer cells.
News

Early-Stage Colon Cancer Cells Hide From the Immune System

A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.
A burning cigarette on a ledge.
News

Epigenetic Markers of Smoking Are Consistent Across Racial and Ethnic Groups

Scientists from the Keck School of Medicine of USC conducted one of the largest multiethnic studies to date of smoking and epigenetics, research that could eventually lead to better ways to predict smoking-related disease risk.
Computer-generated image of cancer cells.
News

Gut Microbiome May Identify Cancer Patients Who Will Respond to Immunotherapy

A signature of bacterial strains in the gut microbiome may be able to identify cancer patients that will respond well to certain immunotherapy drug combinations, according to a new study from Wellcome Sanger Institute and Olivia Newton-John Cancer Research Institute researchers.
Close up of someone's hand attached to a drip.
News

Many Cancer Drugs Lack Proof of Added Benefits, Study Finds

Many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved through expedited (“fast track”) pathways, finds a study published by The BMJ.
A medication drip bag on a stand.
News

More Cancer Patients May Benefit From Personalized Immunotherapy

Patients with cancers that are immunologically "cold" still produce cancer-fighting T cells and therefore may benefit from personalized immunotherapy.
A selection of pills and capsules in different shapes and colors.
News

Streamlined Drug Discovery Approach Proposed by Researchers

New research points to a streamlined approach to drug discovery that allows drug makers to determine the viability of a fragment-based design earlier in the process.
Cancer cells.
News

Study Explores the Role of Mucus in Pancreatic Cancer

CSHL scientists discovered that early pancreatic cancer cells depend on the regulators of mucus production to survive and grow.
A woman smelling flowers.
News

Sniffing Out Surprises Could Shape the Future of Health and Agriculture

Imagine if we could inhale scents that delay the onset of cancer, inflammation, or neurodegenerative disease. Researchers at the University of California, Riverside, are poised to bring this futuristic technology closer to reality.
Cancer cells.
News

Enzyme Checkpoint Identified in Tumor-Associated Immune Cells

A study recently published has a promising result from tumor research: The enzyme phosphoglycerate dehydrogenase (PHDGH) acts as a metabolic checkpoint in the function of tumor-associated macrophages (TAMs) and thus on tumor growth.
Advertisement